These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 288114)

  • 21. [A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria].
    González C; García A; Urrea R; del Solar E; Bello H; Zemelman R
    Rev Med Chil; 1990 May; 118(5):548-54. PubMed ID: 2293275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Determination in vitro of the antibacterial action of Rifampicin (Sinerdol) as compared to other antibiotics].
    Zvorişteanu V; Groll M; Sauciuc A; Teodorovici G
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(3):507-11. PubMed ID: 16296479
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sensitivity of nonfermenting gram-negative bacteria of clinical origin to antibacterial preparations].
    Shchenderov BA; Serkova GP; Tiurin MV
    Antibiotiki; 1984 Mar; 29(3):191-5. PubMed ID: 6732205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Patterns of resistance of Staph aureus and gram-negative bacteria to aminoglycosides and cephalosporins].
    Ruczkowska J; Dolna I
    Wiad Lek; 1989 May; 42(9):579-83. PubMed ID: 2629327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of fosfomycin against 'problem' gram-positive cocci.
    Hamilton-Miller JM
    Microbios; 1992; 71(287):95-103. PubMed ID: 1453987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro antibacterial activity of dibekacin on staphylococci, streptococci and aerobic Gram negative bacilli].
    Deforges L; Van Thoi J; Le Soussy CJ; Duval J
    Nouv Presse Med; 1982 Nov; 11(46):3385-90. PubMed ID: 7155845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of rifampicin on staphylococci and gram negative bacilli isolated from clinical sources].
    Bobrowski M; Dsierzanowska D; Jakubicz P; Borowski J
    Antibiotiki; 1971 Dec; 16(12):1072-6. PubMed ID: 4946556
    [No Abstract]   [Full Text] [Related]  

  • 28. [Development of antibiotic resistance in gram-negative bacteria].
    Bergström S; Elmros T; Holm S; Norlander L; Normark S
    Lakartidningen; 1978 Sep; 75(39):3418-20. PubMed ID: 703423
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro and in vivo evaluation of L/105, a new topical intestinal rifamycin.
    Venturini AP; Marchi E
    Chemioterapia; 1986 Aug; 5(4):257-62. PubMed ID: 3533285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
    Norazah A; Lim VK; Rohani MY; Kamel AG
    Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sensitivity of bacteria isolated from non-parenteral drugs to antibiotics. II. Sensitivity of gram-positive strains].
    Zembrzuska E
    Acta Pol Pharm; 1981; 38(1):123-8. PubMed ID: 6797259
    [No Abstract]   [Full Text] [Related]  

  • 32. Suppression of rifampicin-resistant variants of Staphylococcus aureus.
    Paull A; Marks J
    J Antimicrob Chemother; 1989 Jan; 23(1):161-2. PubMed ID: 2745251
    [No Abstract]   [Full Text] [Related]  

  • 33. Rifampicin resistant strains of bacteria from tuberculosis patients treated with the drug.
    Tanaka T; Inoue M; Mitsuhashi S
    Microbiol Immunol; 1978; 22(9):565-8. PubMed ID: 366343
    [No Abstract]   [Full Text] [Related]  

  • 34. Ro 13-9904: A cephalosporin with a high degree of activity and broad antibacterial activity: an invitro comparative study.
    Wise R; Gillett AP; Andrews JM; Bedford KA
    J Antimicrob Chemother; 1980 Sep; 6(5):595-600. PubMed ID: 7410283
    [No Abstract]   [Full Text] [Related]  

  • 35. Phosphorylative inactivation of rifampicin by Nocardia otitidiscaviarum.
    Yazawa K; Mikami Y; Maeda A; Morisaki N; Iwasaki S
    J Antimicrob Chemother; 1994 Jun; 33(6):1127-35. PubMed ID: 7928806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antibiotic sensitivity of gram-negative opportunistic bacteria isolated from the feces of newborn infants with intestinal infections].
    Litiaeva LA; Zakopaeva ES
    Antibiot Khimioter; 1989 Jan; 34(1):66-8. PubMed ID: 2730219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recovery period after exposure of Staphylococcus aureus to sub-inhibitory and bactericidal concentrations of rifampicin: clinical implications.
    Kitzis MD; Gutmann L; Acar JF
    J Antimicrob Chemother; 1984 Jun; 13 Suppl C():1-5. PubMed ID: 6469886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitive microbiological method for the detection of rifampicin in urine.
    Mitchison DA; Allen BW; Gabriel M; Nunn AJ
    Tubercle; 1974 Sep; 55(3):245-8. PubMed ID: 4620300
    [No Abstract]   [Full Text] [Related]  

  • 39. Tolerance in Staphylococcus aureus.
    Bradley HE; Weldy PL; Hodes DS
    Lancet; 1979 Jan; 1(8108):150. PubMed ID: 84166
    [No Abstract]   [Full Text] [Related]  

  • 40. [Biological properties and antibiotic sensitivity of non-fermenting gram-negative bacteria].
    Shenderov BA
    Antibiot Khimioter; 1988 Feb; 33(2):141-7. PubMed ID: 3288152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.